Skip NavigationSkip to Content

Conformational Switch to a beta-Turn in a Staphylococcal Quorum Sensing Signal Peptide Causes a Dramatic Increase in Potency

  1. Author:
    Vasquez, Joseph K.
    West, Korbin H. J.
    Yang, Tian
    Polaske, Thomas J.
    Cornilescu,Gabriel
    Tonelli, Marco
    Blackwell, Helen E.
  2. Author Address

    Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA.Dow Chem Co USA, 1776 Bldg, Midland, MI 48640 USA.Promega Corp, 2800 Woods Hollow Rd, Madison, WI 53711 USA.Leidos Biomed Res Inc, 8560 Progress Dr, Frederick, MD 21701 USA.
    1. Year: 2020
    2. Date: JAN 15
  1. Journal: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  2. AMER CHEMICAL SOC,
    1. 142
    2. 2
    3. Pages: 750-761
  3. Type of Article: Article
  4. ISSN: 0002-7863
  1. Abstract:

    We report the solution-phase structures of native signal peptides and related analogs capable of either strongly agonizing or antagonizing the AgrC quorum sensing (QS) receptor in the emerging pathogen Staphylococcus epidermidis. Chronic S. epidermidis infections are often recalcitrant to traditional therapies due to antibiotic resistance and formation of robust biofilms. The accessory gene regulator (agr) QS system plays an important role in biofilm formation in this opportunistic pathogen, and the binding of an autoinducing peptide (AIP) signal to its cognate transmembrane receptor (AgrC) is responsible for controlling agr. Small molecules or peptides capable of modulating this binding event are of significant interest as probes to investigate both the agr system and QS as a potential antivirulence target. We used NMR spectroscopy to characterize the structures of the three native S. epidermidis AIP signals and five non-native analogs with distinct activity profiles in the AgrC-I receptor from S. epidermidis. These studies revealed a suite of structural motifs critical for ligand activity. Interestingly, a unique beta-turn was present in the macrocycles of the two most potent AgrC-I modulators, in both an agonist and an antagonist, which was distinct from the macrocycle conformation in the less-potent AgrC-I modulators and in the native AIP-I itself. This previously unknown beta-turn provides a structural rationale for these ligands' respective biological activity profiles. Development of analogs to reinforce the beta-turn resulted in our first antagonist with subnanomolar potency in AgrC-I, while analogs designed to contain a disrupted beta-turn were dramatically less potent relative to their parent compounds. Collectively, these studies provide new insights into the AIP:AgrC interactions crucial for QS activation in S. epidermidis and advance the understanding of QS at the molecular level.

    See More

External Sources

  1. DOI: 10.1021/jacs.9b05513
  2. WOS: 000508475100017

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel